{"id":"NCT00783432","sponsor":"Meda Pharmaceuticals","briefTitle":"Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis","officialTitle":"Active-Controlled Trial of the Safety and Tolerability of a MP03-33 in Patients With Chronic Allergic or Nonallergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2008-10-31","resultsPosted":"2009-10-02","lastUpdate":"2009-10-06"},"enrollment":862,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Allergic Rhinitis","Nonallergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Astepro Nasal Spray (0.1% azelastine hydrochloride)","otherNames":[]},{"type":"DRUG","name":"Astelin Nasal Spray (0.1% azelastine hydrochloride)","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if Astepro Nasal Spray (0.1% azelastine hydrochloride) is as safe as Astelin Nasal Spray (0.1% azelastine hydrochloride)","primaryOutcome":{"measure":"Number of Participants Reporting Adverse Events","timeFrame":"12 months","effectByArm":[{"arm":"Astepro Nasal Spray","deltaMin":207,"sd":null},{"arm":"Astelin Nasal Spray","deltaMin":211,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7},"commonTop":["Headache","Epistaxis","Dysgeusia","Nasopharyngitis","Pharyngolaryngeal Pain"]}}